Manish Mital
@Braidwell Lp
Latest period2024 - Q3ReportedManaged Assets$3.528BTotal holdings81
Assets growth rate10.68%Assets growth rate (2-Q avg)6.71%Continuous growth in asset value3 quarters
Portfolio positions
This chart displays the top 10 holdings in Braidwell Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.
Assets under management
The assets under management (AUM) of Braidwell Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.528B in assets, with a quarterly growth rate of 10.68% and a 2-quarter average growth rate of 6.71%. The portfolio is managed by Manish Mital, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ARVNArvinas Inc
| 0.9% | $31.637M 1.284M shares@ $24.63 avg price | Increased 148.34% |
KRYSKrystal Biotech Inc
| 0.88% | $30.707M 168,691 shares@ $182.04 avg price | Increased 57.4% |
KIDSOrthopediatrics Corp
| 0.86% | $30.032M 1.108M shares@ $27.12 avg price | |
DXCMDexcom Inc
| 0.84% | $29.57M 441,086 shares@ $67.04 avg price | New Position |
BNTXBiontech Se
| 0.84% | $29.425M 247,750 shares@ $118.78 avg price | New Position |
FNAParagon 28 Inc
| 0.79% | $27.623M 4.135M shares@ $6.68 avg price | Decreased -0.36% |
RLAYRelay Therapeutics Inc
| 0.71% | $24.776M 3.499M shares@ $7.08 avg price | Increased 16.39% |
ATECAlphatec Hldgs Inc
| 0.64% | $22.468M 4.041M shares@ $5.56 avg price | Increased 84.12% |
HROWHarrow Inc
| 0.57% | $19.766M 439,638 shares@ $44.96 avg price | Increased 47.94% |
CGEMCullinan Therapeutics Inc
| 0.56% | $19.689M 1.176M shares@ $16.74 avg price | Increased 567.63% |